Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other financing activities (2021)

Ocular Therapeutix has reported Other financing activities over the past 3 years, most recently at $275000.0 for Q1 2021.

  • Quarterly results put Other financing activities at $275000.0 for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $275000.0 (changed N/A YoY), and the annual figure for FY2023 was $5.2 million, changed.
  • Other financing activities for Q1 2021 was $275000.0 at Ocular Therapeutix, up from -$2.4 million in the prior quarter.
  • Over the last five years, Other financing activities for OCUL hit a ceiling of $275000.0 in Q1 2021 and a floor of $275000.0 in Q1 2021.